Firms
Theme

QUAD

QUAD/GRAPHICS, INC. · NYSE

News

3 latest

Zacks Investment Research

Bet on These 4 Stocks With Strong Net Profit Margins to Boost Returns

Four stocks—Nutex Health (NUTX), RCM Technologies (RCMT), Interface (TILE), and Quad/Graphics (QUAD)—were selected based on strong net profit margins, solid EPS growth outlooks, and positive analyst ratings. All four stocks carry Zacks Rank 1 or 2 ratings and VGM Scores of A or B, with recent upward earnings estimate revisions over the past 60 days.

Mentions QUAD

Zacks Investment Research

Best Income Stocks to Buy for October 1st

Recent economic data shows PCE inflation came in softer than expected while Q2 GDP exceeded expectations. Market attention is now focused on the upcoming Friday employment report. Three stocks with strong income characteristics and Zacks Rank #1 ratings are highlighted: BP (energy), Quad Graphics (marketing/print services), and Bridgestone (tires/rubber products).

Zacks Investment Research

New Strong Buy Stocks for October 1st

Recent economic data shows PCE inflation came in softer than expected while Q2 GDP exceeded expectations. Market attention is now focused on Friday's employment report. Five stocks were added to the Zacks Rank #1 (Strong Buy) list based on positive earnings estimate revisions over the last 60 days.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $QUAD · 0 threads

Sign in to post on $QUAD

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev